SSA
MOR

Schonfeld Strategic Advisors’s MorphoSys AG American Depositary Shares MOR Stock Holding History

Schonfeld Strategic Advisors’s Portfolio MOR Stock Details MOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-27,700
Closed -$186K – 2320
2023
Q3 		$186K Buy
+27,700
New +$213K ﹤0.01% 1425
2020
Q4 		– Sell
-34,716
Closed -$1.09M – 1944
2020
Q3 		$1.09M Buy
34,716
+9,912
+40% +$321K 0.02% 679
2020
Q2 		$786K Buy
+24,804
New +$723K 0.02% 680

Other funds holding MOR

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Schonfeld Strategic Advisors's MOR Position: Q4 2023 in Review

Schonfeld Strategic Advisors sold out of MorphoSys AG American Depositary Shares (MOR) in Q4 2023, closing a stake of 27,700 shares — an estimated $186K sold.

Schonfeld Strategic Advisors first reported a position in MOR in Q2 2020 and held it in 3 quarters. The position peaked at $1.09M in Q3 2020. 54 funds tracked by Wall St. Rank hold MOR as of Q4 2023.

  • Schonfeld Strategic Advisors reported no remaining MorphoSys AG American Depositary Shares position as of Q4 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 27,700 MorphoSys AG American Depositary Shares shares in Q4 2023, an estimated $186K.
  • Schonfeld Strategic Advisors first reported a position in MorphoSys AG American Depositary Shares in Q2 2020 and held it in 3 quarters.
  • Schonfeld Strategic Advisors's MorphoSys AG American Depositary Shares position peaked at $1.09M in Q3 2020.
  • 54 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q4 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.